Alyeska Investment Group’s Traws Pharma TRAW Stock Holding History

Alyeska Investment Group’s Portfolio TRAW Stock Details TRAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$139K	Buy	+164,376	New	+$226K	﹤0.01%	649
2025 Q3	–	Sell	-52,630	Closed	-$77.9K	–	741
2025 Q2	$77.9K	Hold	52,630	–	–	﹤0.01%	542
2025 Q1	$121K	Sell	52,630 -64,084	-55%	-$333K	﹤0.01%	490
2024 Q4	$1.04M	Buy	+116,714	New	+$650K	﹤0.01%	494
2021 Q4	–	Sell	-10,000	Closed	-$958K	–	739
2021 Q3	$958K	Buy	+10,000	New	+$1.29M	0.01%	611
2021 Q2	–	Sell	-1,775	Closed	-$665K	–	862
2021 Q1	$665K	Buy	+1,775	New	+$670K	0.01%	642
2015 Q2	–	Sell	-2	Closed	-$221K	–	584
2015 Q1	$221K	Sell	2 -1	-33%	-$164K	﹤0.01%	485
2014 Q4	$487K	Buy	+3	New	+$734K	0.01%	443

Other funds holding TRAW

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

ABG

Ally Bridge Group New York $113M AUM 245.92% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

Alyeska Investment Group's TRAW Position: Q2 2026 in Review

Alyeska Investment Group opened a new position in Traws Pharma (TRAW) in Q2 2026: 164,376 shares worth $139K. The stake represents ﹤0.01% of the portfolio and ranks #649 among its holdings. This is a return to the name: Alyeska Investment Group previously reported a position in TRAW as recently as Q2 2025.

Alyeska Investment Group first reported a position in TRAW in Q4 2014 and has held it in 8 quarters since. The position peaked at $1.04M in Q4 2024. 35 funds tracked by Wall St. Rank hold TRAW as of Q2 2026.

Alyeska Investment Group held 164,376 shares of Traws Pharma worth $139K as of Q2 2026.
Traws Pharma was a new Alyeska Investment Group position in Q2 2026.
Traws Pharma made up ﹤0.01% of Alyeska Investment Group's portfolio in Q2 2026, its #649 holding.
Alyeska Investment Group first reported a position in Traws Pharma in Q4 2014 and has held it in 8 quarters since.
Alyeska Investment Group's Traws Pharma position peaked at $1.04M in Q4 2024.
35 funds tracked by Wall St. Rank held Traws Pharma as of Q2 2026.

Based on Alyeska Investment Group's 13F filing for Q2 2026, filed 14 Aug 2026.